To receive daily emails from Breaking Christian News to your inbox CLICK HERE

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial. It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB." –Dr. William Jacobs, Jr.

(Bronx, NY)—In a striking, unexpected discovery, researchers at Albert Einstein College of Medicine of Yeshiva University have determined that vitamin C kills drug-resistant tuberculosis (TB) bacteria in laboratory culture. The finding suggests that vitamin C added to existing TB drugs could shorten TB therapy, and it highlights a new area for drug design. The study was published today in the online journal Nature Communications.

TB is caused by infection with the bacterium M. tuberculosis. In 2011, TB sickened some 8.7 million people and took some 1.4 million lives, according to the World Health Organization. Infections that fail to respond to TB drugs are a growing problem: About 650,000 people worldwide now have multi-drug-resistant TB (MDR-TB), 9 percent of whom have extensively drug-resistant TB (XDR-TB).TB is especially acute in low and middle income countries, which account for more than 95 percent of TB-related deaths, according to the World Health Organization.

The Einstein discovery arose during research into how TB bacteria become resistant to isoniazid, a potent first-line TB drug. The lead investigator and senior author of the study was William Jacobs, Jr. Ph.D., professor of microbiology and microbiology and of genetics at Einstein. Dr. Jacobs is a Howard Hughes Medical Institute investigator and a recently elected member of the National Academy of Sciences. (Photo by: Shaun W)

Dr. Jacobs and his colleagues observed that isoniazid-resistant TB bacteria were deficient in a molecule called mycothiol.

"We hypothesized that TB bacteria that can't make mycothiol might contain more cysteine, an amino acid," said Dr. Jacobs. "So, we predicted that if we added isoniazid and cysteine to isoniazid-sensitive M. tuberculosis in culture, the bacteria would develop resistance. Instead, we ended up killing off the culture— something totally unexpected."

The Einstein team suspected that cysteine was helping to kill TB bacteria by acting as a "reducing agent" that triggers the production of reactive oxygen species (sometimes called free radicals), which can damage DNA.

"To test this hypothesis, we repeated the experiment using isoniazid and a different reducing agent— vitamin C," said Dr. Jacobs. "The combination of isoniazid and vitamin C sterilized the M. tuberculosis culture. We were then amazed to discover that vitamin C by itself not only sterilized the drug-susceptible TB, but also sterilized MDR-TB and XDR-TB strains."

To justify testing vitamin C in a clinical trial, Dr. Jacobs needed to find the molecular mechanism by which vitamin C exerted its lethal effect. More research produced the answer: Vitamin C induced what is known as a Fenton reaction, causing iron to react with other molecules to create reactive oxygen species that kill the TB bacteria.

"We don't know whether vitamin C will work in humans, but we now have a rational basis for doing a clinical trial," said Dr. Jacobs. "It also helps that we know vitamin C is inexpensive, widely available and very safe to use. At the very least, this work shows us a new mechanism that we can exploit to attack TB."

The paper is titled, "Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction." The other contributors are Catherine Vilcheze, Ph.D., Travis Hartman and Brian Weinrick, Ph.D., all at Einstein.

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

Americans Split On Pastors Using AI, Skeptical It Can Help With Understanding the Bible

Daughters of the American Revolution to Vote on Definition of 'Woman' amid Criticism of Transgender Policy

FYI: These 568 Companies Are Paying to Trans Kids. A Nationwide Campaign Demands They Stop

'They Paid Me to Vote': Homeless Residents Make Explosive Claims after Spencer Pratt's Loss [Video]

America Becomes India's Top Gas Supplier amid Strait of Hormuz Conflict

Netanyahu: 'Iran Will Not Have Nuclear Weapons'

'Fauci, Biden Admin Lied to American People': DNI Gabbard Reveals Evidence of US Taxpayer-Funded Global Biolab Program

Human Trafficking Update: Feds Identify 15,500 Sponsors of Multiple Unaccompanied Kids

Ainsley Earhardt Celebrates America; Reveals Supernatural Experience That Strengthened Her Faith [Video]

Melania Trump Launches First-of-Its-Kind Foster Youth Accounts to Give Children Asset Ownership

Changing Tide: Record-low 38% of Americans Support 'Gender Transitions' - Gallup Poll

4 States Offering Pride Month Alternatives That Celebrate Family

PRO-LIFE WIN: Trump Admin Moves to Remedy Downfall of IVF

Karmelo Anthony Claims He's 'Penniless,' Can't Afford Lawyer for Appeal, Despite Pocketing $625,000, after Murder Conviction

Trump Says US Snuck 22 Oil Ships Past Iran in Covert Op, US Strikes Regime 2 Nights in a Row

Memphis Safe Task Force Surpasses 10,000 Arrests, Locates 154 Missing Children and Removes over 1,700 Firearms from City Streets

President Trump Signs $70 Billion Border Security, ICE Funding Bill that Includes Funding to Combat Child Trafficking

Report: Parents Remain Essential to Instilling Authentic Faith in Next Generation

Who Is Counseling Our Children?

Supreme Court Vacates Biden-Era Decision Outlawing Gas Stoves, Water Heaters

Steve Shultz, Managing Editor
Founder and Owner

Aimee Herd, Editor